RxDoctor Payments Data

Raymond Reyes, PA

Physician Assistant · Blackwood, NJNPI 1750055968

Payments from drug & device makers

$5,416in general payments, 2019–2025

Across 327 payments — averaging $16.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Collegium Pharmaceutical, Inc.$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
  • Nalu Medical, Inc.$798
  • Boston Scientific$359
  • Valinor Pharma, LLC$317
  • AbbVie$253
  • plus $972 from 22 others

What the payments were for

  • Travel & lodging$3126%
  • Food & beverage$5,08294%
  • Education$210%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,416 in reported general payments places this provider in the 95th percentile of 2,726 physician assistant providers in New Jersey.

See all physician assistant providers in New Jersey

Medicare billing

Part B allowed, 2024
$65,260
Medicare patients
142
Services billed
936

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RelistorMethylnaltrexone Bromide211$499,884
BelbucaBuprenorphine Hcl207$186,315
ZtlidoLidocaine97$98,535
Xtampza ErOxycodone Myristate138$61,522
Buprenorphine146$39,502
UbrelvyUbrogepant20$35,012
OxycontinOxycodone Hcl52$26,781
Oxycodone Hcl964$23,455
MovantikNaloxegol Oxalate59$23,412
Diclofenac Sodium90$23,070
Hysingla ErHydrocodone Bitartrate60$22,768
HorizantGabapentin Enacarbil34$21,705
Nurtec OdtRimegepant Sulfate19$19,257
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen691$16,676
LinzessLinaclotide23$11,845

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$1,338$499,884211 claims
Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er$1,380$247,837345 claims
AbbVieUbrelvy, Linzess$253$46,85643 claims
Hikma Pharmaceuticals USABuprenorphine, Buprenorphine-Naloxone, Morphine Sulfate, Buprenorphine Hcl$33$43,676236 claims
Arbor Pharmaceuticals, Inc.Horizant$31$21,70534 claims
PfizerNurtec Odt$45$19,25719 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,726 physician assistant providers in New Jersey.

Other physician assistant in Blackwood

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →